AOSSM: Surgery Better for Acute Proximal Hamstring Ruptures

This article originally appeared here.
Share this content:
AOSSM: Surgery Better for Acute Proximal Hamstring Ruptures
AOSSM: Surgery Better for Acute Proximal Hamstring Ruptures

MONDAY, July 13, 2015 (HealthDay News) -- For patients with acute proximal hamstring ruptures, surgical repair is associated with better lower extremity function, according to a study presented at the annual meeting of the American Orthopaedic Society for Sports Medicine, held from July 9 to 12 in Orlando, Fla.

Joshua Olsen, M.D., from the New England Baptist Hospital in Boston, and colleagues compared the clinical results of non-operative and operative treatment of acute proximal hamstring ruptures in a retrospective case-control study. At the time of initial evaluation, patients were given the option of a proximal hamstring repair. Twenty-five patients were enrolled, of whom 14 were treated surgically and 11 were treated non-operatively.

The researchers found that the lower extremity function score was 74.71 ± 5.38 for the surgical group and 68.5 ± 7.92 for the nonsurgical group (P = 0.04). In the surgical and nonsurgical groups, the average single leg hop of the injured extremity was 119.1 ± 27.68 cm and 56.1 ± 31.2 cm, respectively (P = 0.0001); the average single leg hop in the injured leg was shorter in both groups compared with the uninjured leg. All patients in the operative group were able to return to pre-injury activities; three in the non-operative group were unable to do so (P = 0.03).

"While the study size does have limitations, the significant benefit for those treated surgically cannot be ignored," Olsen said in a statement. "This information can help us in making future treatment recommendations to patients experiencing similar hamstring injuries."

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »